scispace - formally typeset
Book ChapterDOI

Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death.

TLDR
It is concluded that the methodology generates highly efficient transducible proteins that are biologically active and have broad potential in the manipulation of biological experimental systems, such as apoptotic induction, cell cycle progression, and differentiation, and in the delivery of pharmacologically relevant proteins.
Abstract
Currently, delivery of expression vectors, proteins, and/or pharmacologically important peptidyl mimetics to target cells is problematic because of the low percentage of cells targeted, overexpression, size constraints, and bioavailability Concentration-dependent transduction of full-length proteins and domains directly into cells would serve to alleviate these problems Previous researchers have demonstrated the ability of proteins linked to the human immunodeficiency virus (HIV) Tat transduction domain to transduce into cells; but because of inefficiencies, this methodological potential has not significantly progressed since 1988 We describe, in this chapter, a significant increase in transduction efficiency of proteins and ease of use by (1) generation of a Tat protein transduction domain in-frame bacterial expression vector, pTAT-HA, and (2) development of a purification protocol yielding denatured proteins We have transduced full-length Tat fusion proteins ranging in size from 15 to 115 kDa into approximately 100% of all target cells examined, including peripheral blood lymphocytes, all cells present in whole blood, bone marrow stem cells, diploid fibroblasts, fibrosarcoma cells, and keratinocytes Transduction occurs in a concentration-dependent manner, achieving maximum intracellular concentrations in less than 10 min We conclude that our methodology generates highly efficient transducible proteins that are biologically active and have broad potential in the manipulation of biological experimental systems, such as apoptotic induction, cell cycle progression, and differentiation, and in the delivery of pharmacologically relevant proteins

read more

Citations
More filters
Journal ArticleDOI

Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics

TL;DR: This review will focus on the structure/function and cellular uptake mechanism of CPPs in the general context of drug delivery, and highlight the application of peptide carriers for the delivery of therapeutic molecules and provide an update of their clinical evaluation.
Journal ArticleDOI

TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors

TL;DR: It is demonstrated that relatively large drug carriers, such as 200-nm liposomes, can also be delivered into cells by TAT peptide attached to the liposome surface, confirming the energy-independent character of this process.
Journal ArticleDOI

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

TL;DR: This review attempts to summarize currently available information regarding targeted pharmaceutical nanocarriers for cancer therapy and imaging, as well as different ways to target tumors via specific ligands and via the stimuli sensitivity of the carriers.
Journal ArticleDOI

Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.

TL;DR: The delivery of different molecules and particles mediated by TAT, Antp, VP22, and other CPPs are reviewed as well as potential applications of these delivery systems in different areas of vaccine development, cancer immunotherapy, gene delivery, and cellular imaging.
Journal ArticleDOI

Delivery of bioactive molecules into the cell: the Trojan horse approach

TL;DR: An extensive review of peptide-mediated protein transduction from its early beginnings to new advances, and their application, with particular focus on a critical evaluation of the limitations of the method, as well as alternative approaches.
References
More filters
Journal ArticleDOI

Cancer Cell Cycles

TL;DR: Genetic alterations affecting p16INK4a and cyclin D1, proteins that govern phosphorylation of the retinoblastoma protein and control exit from the G1 phase of the cell cycle, are so frequent in human cancers that inactivation of this pathway may well be necessary for tumor development.
Journal ArticleDOI

Cellular uptake of the tat protein from human immunodeficiency virus

TL;DR: Experiments using radioactive protein show that tat becomes localized to the nucleus after uptake and suggest that chloroquine protects tat from proteolytic degradation, raising the possibility that, under some conditions, tat might act as a viral growth factor to stimulate viral replication in latently infected cells or alter expression of cellular genes.
Journal ArticleDOI

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus

TL;DR: The main determinants required for Tat translocation within this sequence are delineated by synthesizing several peptides covering the Tat domain from residues 37 to 60 and the domain extending from amino acid 37 to 47, which corresponds to the α-helix structure, is not required for cellular uptake and for nuclear translocation.
Journal ArticleDOI

The third helix of the Antennapedia homeodomain translocates through biological membranes

TL;DR: It is reported here that a polypeptide of 16 amino acids in length corresponding to the third helix of the homeodomain deleted of its N-terminal glutamate is still capable of translocating through the membrane, suggesting an energy-independent mechanism of translocation not involving classical endocytosis.
Journal ArticleDOI

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

TL;DR: HIV-1 encodes a potent trans-activator protein, tat, which is essential for viral gene expression, and chemically synthesized the 86 amino acid tat protein (tat-86) and tat mutant peptides, demonstrating the functional significance of these domains.
Related Papers (5)